New York, New York, United States Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2018. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity.
The overall number of key employees were 2.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Amzak Health Investors, startups are often financed by additional investors, NFL Players Association, DSM Venturing. The meaningful sponsors for the fund in investment in the same round are additional investors, NFL Players Association, DSM Venturing. In the next rounds fund is usually obtained by additional investors, NFL Players Association, DSM Venturing.
Among the various public portfolio startups of the fund, we may underline Miach Orthopaedics, Miach Orthopaedics, ShiraTronics Among the most popular fund investment industries, there are Wellness, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| Advanced MedTech Holdings (AMTH) | Central, Central Region, Singapore |
| Bio-Rad Laboratories | California, Hercules, United States |
| Black Kite Capital | - |
| CECONOMY | - |
| Datasection | Japan, Tokyo |
| Dorset Capital | Brazil, São Paulo, Sao Paulo |
| Guangzhou Shi Bingdu Touzi Hehuo Qiye (Limited Partnership) | China, Guangdong, Guangzhou |
| Hitron Technology | - |
| Jefferson Corner Group | Charlottesville, United States, Virginia |
| Kairos Partners | Michigan, Milan, United States |
| Kineticos Disruptor Fund | North Carolina, Raleigh, United States |
| Marker Hill Capital | Colorado, Denver, United States |
| Northern Ontario Angels | Canada, Ontario, Thunder Bay |
| Orange County Code School | California, Newport Beach, United States |
| RTP-HC | - |
| Samson Venture Partners | District of Columbia, United States, Washington |
| SEDIA SYSTEM | Japan, Tokyo |
| Signal Ventures | England, London, United Kingdom |
| Yuan Capital | China, Hong Kong, Hong Kong Island |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ShiraTronics | 30 Sep 2024 | Minneapolis, Minnesota, United States | |||
Synergy Disc Replacement Inc | $30M | 31 Jan 2024 | Cambridge, Ontario, Canada | ||
Miach Orthopaedics | $30M | 25 Jan 2023 | Boston, Massachusetts, United States | ||
LQT Therapeutics | $19M | 10 Aug 2021 | Laval, Quebec, Canada | ||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
| $95M | 12 Mar 2021 | Basel, Basel-City, Switzerland | |||
Neuros Medical | $38M | 07 Jan 2021 | Ohio, United States | ||
Reneo Pharmaceuticals | $95M | 09 Dec 2020 | San Diego, California, United States | ||
| $96M | 24 Sep 2020 | Basel, Basel-City, Switzerland |
– Antios Therapeutics from San Diego, CA announced the successful completion of a $96m Series B financing.
– The financing was led by Soleus Capital with participation from new major investors RA Capital Management, Adage Capital Management LP, Pontifax and Aisling Capital as well as other healthcare focused funds, Altium Capital, Amzak Health, Granite Point Capital Management, LP, and LifeSci Venture Partners and participation from all of the original Series A investors including Lumira Ventures, CAM Capital, Delos Capital, Domain Associates and Sixty Degree Capital.
– Antios Therapeutics is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ShiraTronics | 30 Sep 2024 | Minneapolis, Minnesota, United States | |||
Synergy Disc Replacement Inc | $30M | 31 Jan 2024 | Cambridge, Ontario, Canada | ||
Miach Orthopaedics | $30M | 25 Jan 2023 | Boston, Massachusetts, United States | ||
LQT Therapeutics | $19M | 10 Aug 2021 | Laval, Quebec, Canada | ||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
| $95M | 12 Mar 2021 | Basel, Basel-City, Switzerland | |||
Neuros Medical | $38M | 07 Jan 2021 | Ohio, United States | ||
Reneo Pharmaceuticals | $95M | 09 Dec 2020 | San Diego, California, United States | ||
| $96M | 24 Sep 2020 | Basel, Basel-City, Switzerland |
